FindTrial
Sign In

Role of meditation in patients with glaucoma

evaluation of effect of mindfulness based stress reduction in patients with primary open angle glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013397
Enrollment
60
Registered
2018-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Glaucoma

Interventions

Intervention1: Meditation: patients will undergo meditation for 6 weeks in addition to their standard medical management Control Intervention1: standard medical management: they will continue with the

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Primary Open Angle Glaucoma and Primary angle closure glaucoma with moderate to advanced visual field changes[H.P.A classification] Age > 45 years Visual Acuity of the Better eye > 6/60

Exclusion criteria

Exclusion criteria: other ocular co morbid conditions affecting visual acuity other systemic conditions affecting quality of life physically handicapped patients uncontrolled glaucoma

Design outcomes

Primary

MeasureTime frame
change in intraocular pressure with mindfulness based stress reductionTimepoint: baseline, 2 weeks, 6 weeks—

Secondary

MeasureTime frame
Quality of life, visual acuity, visual field, fundus changes serum cortisol, serum endorphin, serum IL-6, serum IL-2,BDNF, reactive oxygen species and brain oxygenationTimepoint: baseline, 2 weeks, 6 weeks—

Countries

India

Contacts

Public ContactMeghal Gagrani

Dr. R.P. centre for Ophthalmic sciences

Meghal.gagrani@gmail.com9971005530

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026